Preview

Study of postvaccinal immunity to whooping cough in children with connective tissue dyslasia syndrome

https://doi.org/10.22627/2072-8107-2021-20-1-28-33

Abstract

Purpose: to evaluate the effectiveness of post-vaccination immunity against whooping cough in children aged 1 to 17 years with connective tissue dysplasia syndrome in Stavropol.

The principal component analysis was used to optimize the interpretation of immunograms in connective tissue dysplasia syndromedepending on protective titers for whooping cough. Analysis by the method of principal components showed that the links of cellular immunity predominate in children with connective tissue dysplasia syndrome with low titers of antibodies to whooping cough.The general variant of the response of the immune system was observed in children with protective titers of antibodies to whooping cough (1: 160—1: 320). In children with connective tissue dysplasia with titres of 1: 640or more antibodies to whooping cough, humoral and cellular immunities are closely interrelated, it is the presence of humoral and cellular immunity that makesit possible to develop a stable immunity to preventable infections.

Thus, the method of main components effectively provides accessible information on key immune processes and is promising.

About the Authors

S. M. Bezrodnova
Stavropol State Medical University of the Ministry of Healthcare of the Russian Federation
Russian Federation

MD, professor



I. V. Demurcheva
Stavropol State Medical University of the Ministry of Healthcare of the Russian Federation
Russian Federation


O. O. Kravchenko
Stavropol State Medical University of the Ministry of Healthcare of the Russian Federation
Russian Federation

 PhD



References

1. On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2018: State report. M.: Federal Service for Supervision of Consumer Rights Protection and Human Welfare, 2020:299. (In Russ.)

2. Wendelboe AM, Van Rie A, Salmaso S, Englund JA et al. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005; 24 (5 Suppl): S58—S61.

3. WHO. Pertussis vaccines: WHO position paper — August 2015. Weekly Epidemiol Rec. 2015; 90:433—460. http://www.who.int/entity/wer/2015/wer9035.pdf.

4. Popova O. L., Gorelov A.V. Modern aspects of pertussis in children. Moscow: GEOTAR-Media, 2017:192 (In Russ.)

5. Kaplina S.P., Кharit S.M., Skripchenko N.V. Vaccinoprophylaxis in Russia in modern conditions. Russian Bulletin of Perinatology and Pediatrics. 2018; 1:5—13. (In Russ.)

6. Shamsheva O.V., Uchaikin V.F., Medunitsyn N.V. In. Clinical Vaccinology.M.: GEOTAR-Media, 2016: 576. (In Russ.)

7. Zaitsev. E.M., Mazurova I.K., Krasnoproshina L.I. et al. Humoral pertussis immunity and the prevalence of whooping cough in the population. Journal of Microbiology, Epidemiology and Immunology. 2009, 1: 56—58. (In Russ.)

8. Kaplina S.P., Iosefovich O.V. Immunological efficacy of vaccination against diphtheria and pertussis in children with nervous system pathology (data from preliminary studies). Epidemiology and Vaccine Prophylaxis.2011.5 (60): 33—38. (In Russ.)


Review

For citations:


Bezrodnova S.M., Demurcheva I.V., Kravchenko O.O. Study of postvaccinal immunity to whooping cough in children with connective tissue dyslasia syndrome. CHILDREN INFECTIONS. 2021;20(1):28-33. (In Russ.) https://doi.org/10.22627/2072-8107-2021-20-1-28-33

Views: 706


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-8107 (Print)
ISSN 2618-8139 (Online)